The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of bridging chemotherapy on clinical outcome of CD19 CAR T therapy in adult ALL.
 
Karlo Perica
Patents, Royalties, Other Intellectual Property - Royalties from technology licensed to Neximmune, Inc.
 
Jessica Flynn
No Relationships to Disclose
 
Kevin Joseph Curran
Consulting or Advisory Role - Novartis
Research Funding - Juno Therapeutics
 
Xiuyan Wang
No Relationships to Disclose
 
Elizabeth Halton
No Relationships to Disclose
 
Claudia Diamonte
Travel, Accommodations, Expenses - Juno Therapeutics
 
John Pineda
No Relationships to Disclose
 
Yvette Bernal
No Relationships to Disclose
 
Mithat Gonen
Consulting or Advisory Role - Tesaro
 
Isabelle Riviere
Stock and Other Ownership Interests - Juno Therapeutics
Consulting or Advisory Role - Juno Therapeutics
Research Funding - Juno Therapeutics
Patents, Royalties, Other Intellectual Property - Juno Therapeutics
 
Michel Sadelain
Consulting or Advisory Role - Juno Therapeutics
Research Funding - Atara Biotherapeutics; Fate Therapeutics; Juno Therapeutics; Takeda; Takeda; Takeda; Takeda
Patents, Royalties, Other Intellectual Property - Licensed patent to Juno Therapeutics.
Other Relationship - Berkeley Lights
 
Renier J. Brentjens
Stock and Other Ownership Interests - JUNO Therapeutics
Consulting or Advisory Role - JUNO Therapeutics
Research Funding - JUNO Therapeutics
Patents, Royalties, Other Intellectual Property - Scientific Cofounder of JUNO therapeutics
 
Jae Hong Park
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Kite, a Gilead company; Novartis; Pfizer
Research Funding - Genentech/Roche (Inst); Juno Therapeutics (Inst)